Autori: Lentz SR
Naslov | Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2 (Meeting Abstract) |
Autori | Tiede Andreas Janic Dragana M Ozelo M Santagostino E Korsholm Lars Matytsina Irina Lentz SR |
Info | HAEMOPHILIA, (2018), vol. 24 br. , Suppl. S1, str. 52-52 |
Projekat | Alnylam; Baxter/Baxalta/Shire; Bayer; Biogen Idec; Biotest; CSL Behring; Novo Nordisk A/S; Octapharma; Pfizer; Roche; Sobi; Baxter; Shire |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Interim results from a large multinational extension trial (guardian (TM) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Letter) |
Autori | Lentz SR Cerqueira MH Janic Dragana M Kempton CL Matytsina Irina Misgav M Oldenburg J Ozelo M Recht M Rosholm A Savic Aleksandar D Suzuki Takashi Tiede Andreas Santagostino E |
Info | HAEMOPHILIA, (2016), vol. 22 br. 5, str. E445-E449 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Meeting Abstract) |
Autori | Lentz SR Kempton CL Janic Dragana M Savic Aleksandar D Cerqueira MH Ozelo MC Recht M Oldenburg J Tiede Andreas Suzuki Takashi Matytsina Irina Zeuthen N Santagostino E |
Info | JOURNAL OF THROMBOSIS AND HAEMOSTASIS, (2015), vol. 13 br. , Suppl. 2, str. 842-842 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Safety and efficacy of turoctocog alfa (NovoEight (R)) during surgery in patients with haemophilia A: results from the multinational guardian (TM) clinical trials (Article) |
Autori | Santagostino E Lentz SR Misgav M Brand B Chowdary Pratima Savic Aleksandar D Kilinc Yurdanur Amit Y Amendola A Solimeno LP Saugstrup T Matytsina Irina |
Info | HAEMOPHILIA, (2015), vol. 21 br. 1, str. 34-40 |
Projekat | Novo Nordisk A/S (Bagsvaerd, Denmark) |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Results from a large multinational clinical trial (guardian (TM) 1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy (Article) |
Autori | Lentz SR Misgav M Ozelo MC Salek SZ Veljkovic Dobrila K Recht M Cerqueira MH Tiede Andreas Brand B Mancuso ME Seremetis S Lindblom A Martinowitz U |
Info | HAEMOPHILIA, (2013), vol. 19 br. 5, str. 691-697 |
Projekat | Novo Nordisk A/S (Bagsvaerd, Denmark) |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Surgery with Turoctocog Alfa: Efficacy and Safety in Bleeding Prevention During Surgical Procedures - Results From the guardian (TM) Trials (Meeting Abstract) |
Autori | Santagostino Elena Lentz SR Misgav M Brand B Chowdary Pratima Savic Aleksandar D Kilinc Yurdanur Tuddenham Edward GD Lindblom A |
Info | BLOOD, (2012), vol. 120 br. 21, str. - |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Safety and efficacy of turoctocog alfa during prevention and treatment of bleeds in adult and adolescent patients with severe haemophilia A (Meeting Abstract) |
Autori | Lentz SR Misgav M Ozelo MC Zupancic-Salek Silva Veljkovic Dobrila K Recht M Cerqueira MH Tiede Andreas Brand B Mancuso ME Martinowitz U |
Info | HAEMOPHILIA, (2012), vol. 18 br. 5, str. 829-830 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|